Home › Funds › ProShare Advisors LLC › WST

ProShare Advisors LLC position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

ProShare Advisors LLC reported holding 598,024 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q2 2026 13F filing — a position valued at US$214.7M, representing 0.31% of its reported portfolio and ranking #48 among its reported holdings. ProShare Advisors LLC has disclosed WST holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)598.02K sh
Reported value held$214.69M
Portfolio Weight0.31%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ProShare Advisors LLC's WST position evolved

ProShare Advisors LLC first disclosed a stake in WST in Q3 2023 at 488,765 shares (US$183.4M). The position peaked in Q3 2024 at 1,111,556 shares, worth US$333.6M. Across 12 filings, ProShare Advisors LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 598,024 shares valued at US$214.7M — a reduction of -62,060 shares quarter over quarter.. Notable position changes include a 138% increase in Q3 2024 (shares rose 9% over the following quarter), a 48% trim in Q4 2024 (shares fell 32% over the following quarter), a 47% increase in Q2 2025 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 488.76K $183.39M New
Q4 2023 439.42K $154.73M Reduce
Q1 2024 500.66K $198.12M Add
Q2 2024 466.81K $153.76M Reduce
Q3 2024 1.11M $333.64M Add
Q4 2024 577.97K $189.32M Reduce
Q1 2025 503.10K $112.63M Reduce
Q2 2025 738.37K $161.55M Add
Q3 2025 612.62K $160.71M Reduce
Q4 2025 586.85K $161.47M Reduce
Q1 2026 660.08K $165.44M Add
Q2 2026 598.02K $214.69M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 34 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has ProShare Advisors LLC held WST?

ProShare Advisors LLC has disclosed WST holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ProShare Advisors LLC's current position in WST?

As of Q2 2026, ProShare Advisors LLC holds 598.02K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $214.69M, representing 0.31% of its reported portfolio and ranking #48.

Has ProShare Advisors LLC been buying or selling WST?

In the latest 13F filing (Q2 2026), ProShare Advisors LLC reduced its position in WST. The position peaked in Q3 2024 at 1.11M shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.